Cargando…

Indications and outcomes for intravitreal injection of C(3)F(8) gas for symptomatic vitreomacular traction

To evaluate the indications and outcomes of perfluoropropane (C3F8) gas injection for symptomatic vitreomacular traction (VMT). A retrospective analysis of eyes with VMT treated with 0.3 mL of C3F8 gas was performed. Patients were not asked to posture after gas injection. In phakic patients, catarac...

Descripción completa

Detalles Bibliográficos
Autores principales: Guber, Josef, Rusch, Celine, Guber, Ivo, Scholl, Hendrik P. N., Valmaggia, Christophe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433203/
https://www.ncbi.nlm.nih.gov/pubmed/34508148
http://dx.doi.org/10.1038/s41598-021-97639-z
_version_ 1783751328889044992
author Guber, Josef
Rusch, Celine
Guber, Ivo
Scholl, Hendrik P. N.
Valmaggia, Christophe
author_facet Guber, Josef
Rusch, Celine
Guber, Ivo
Scholl, Hendrik P. N.
Valmaggia, Christophe
author_sort Guber, Josef
collection PubMed
description To evaluate the indications and outcomes of perfluoropropane (C3F8) gas injection for symptomatic vitreomacular traction (VMT). A retrospective analysis of eyes with VMT treated with 0.3 mL of C3F8 gas was performed. Patients were not asked to posture after gas injection. In phakic patients, cataract surgery was performed simultaneously. Patients were examined after one week and one month postoperatively. Twenty-nine consecutive eyes of 26 patients with symptomatic VMT who underwent pneumatic vitreolysis were included. A complete posterior vitreous detachment was achieved in 18 eyes (62.1%) after a single gas injection at the final visit. The rate of posterior vitreous detachment was reduced significantly with the presence of epiretinal membrane (ERM) (p = 0.003). Three eyes formed a macular hole (MH) postoperatively and another eye developed a retinal detachment. Mean visual acuity increased significantly after one month (p < 0.008). Pneumatic vitreolysis is a viable option for treating VMT with few adverse events. Patient with concomitant ERM had a significantly lower success rate.
format Online
Article
Text
id pubmed-8433203
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-84332032021-09-13 Indications and outcomes for intravitreal injection of C(3)F(8) gas for symptomatic vitreomacular traction Guber, Josef Rusch, Celine Guber, Ivo Scholl, Hendrik P. N. Valmaggia, Christophe Sci Rep Article To evaluate the indications and outcomes of perfluoropropane (C3F8) gas injection for symptomatic vitreomacular traction (VMT). A retrospective analysis of eyes with VMT treated with 0.3 mL of C3F8 gas was performed. Patients were not asked to posture after gas injection. In phakic patients, cataract surgery was performed simultaneously. Patients were examined after one week and one month postoperatively. Twenty-nine consecutive eyes of 26 patients with symptomatic VMT who underwent pneumatic vitreolysis were included. A complete posterior vitreous detachment was achieved in 18 eyes (62.1%) after a single gas injection at the final visit. The rate of posterior vitreous detachment was reduced significantly with the presence of epiretinal membrane (ERM) (p = 0.003). Three eyes formed a macular hole (MH) postoperatively and another eye developed a retinal detachment. Mean visual acuity increased significantly after one month (p < 0.008). Pneumatic vitreolysis is a viable option for treating VMT with few adverse events. Patient with concomitant ERM had a significantly lower success rate. Nature Publishing Group UK 2021-09-10 /pmc/articles/PMC8433203/ /pubmed/34508148 http://dx.doi.org/10.1038/s41598-021-97639-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Guber, Josef
Rusch, Celine
Guber, Ivo
Scholl, Hendrik P. N.
Valmaggia, Christophe
Indications and outcomes for intravitreal injection of C(3)F(8) gas for symptomatic vitreomacular traction
title Indications and outcomes for intravitreal injection of C(3)F(8) gas for symptomatic vitreomacular traction
title_full Indications and outcomes for intravitreal injection of C(3)F(8) gas for symptomatic vitreomacular traction
title_fullStr Indications and outcomes for intravitreal injection of C(3)F(8) gas for symptomatic vitreomacular traction
title_full_unstemmed Indications and outcomes for intravitreal injection of C(3)F(8) gas for symptomatic vitreomacular traction
title_short Indications and outcomes for intravitreal injection of C(3)F(8) gas for symptomatic vitreomacular traction
title_sort indications and outcomes for intravitreal injection of c(3)f(8) gas for symptomatic vitreomacular traction
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8433203/
https://www.ncbi.nlm.nih.gov/pubmed/34508148
http://dx.doi.org/10.1038/s41598-021-97639-z
work_keys_str_mv AT guberjosef indicationsandoutcomesforintravitrealinjectionofc3f8gasforsymptomaticvitreomaculartraction
AT ruschceline indicationsandoutcomesforintravitrealinjectionofc3f8gasforsymptomaticvitreomaculartraction
AT guberivo indicationsandoutcomesforintravitrealinjectionofc3f8gasforsymptomaticvitreomaculartraction
AT schollhendrikpn indicationsandoutcomesforintravitrealinjectionofc3f8gasforsymptomaticvitreomaculartraction
AT valmaggiachristophe indicationsandoutcomesforintravitrealinjectionofc3f8gasforsymptomaticvitreomaculartraction